Claire Crowley

Claire Crowley

Auto-generated profile, based on publicly available information

Claire Crowley

From the Department of Radiology, Division of Breast Imaging (J.N.T., C.C., M.A.S.) and Department of Pathology (J.V., B.B., V.B.), Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (X.H.); Department of Pathology, Newton-Wellesley Hospital, Newton, Mass (V.V.M., M.A.T.); and Department of Pathology, Cleveland Clinic, Cleveland, Ohio (P.J.M.).

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2025 in RadioGraphics
Verified
Journal Article
Closed access
JTJanice N. Thai
Janice N. Thai
JVJasmine Vickery
Jasmine Vickery
BBBaris Boyraz
Baris Boyraz
CCClaire Crowley
Claire Crowley
MSMansi A. Saksena
Mansi A. Saksena
VBVeerle Bossuyt
Veerle Bossuyt
Papillary lesions of the breast are characterized by the presence of central fibrovascular cores and span the spectrum from benign to malignant, and management ranges from surgical excision to surveillance, with consideration of radiologic-pathologic concordance.

17 July 2023 in Lung
Verified
Journal Article
Open access
PDF file
AOAlexander O'Mahony
Alexander O'Mahony
PHPatrick J. Henry
Patrick J. Henry
PCPatrick Coghlan
Patrick Coghlan
MWMichael Gerard Waldron
Michael Gerard Waldron
CCClaire Crowley
Claire Crowley
MHMichael T. Henry
Michael T. Henry
Purpose: Interstitial lung disease (ILD) is the most common non-musculoskeletal manifestation of idiopathic inflammatory myopathies (IIM). Identification of body composition change may enable early intervention to improve prognosis. We investigated muscle quantity and quality derived from cross-sectional imaging in IIM, and its relationship to ILD severity. Methods: A retrospective cohort study assessing IIM of ILD patients (n = 31) was conducted. Two datasets separated in time were collected, containing demographics, biochemical data, pulmonary function testing and thoracic CT data. Morphomic analysis of muscle quantity (cross-sectional area) and quality (density in Hounsfield Units) on thoracic CT were analysed utilising a web-based tool allowing segmentation of muscle and fat. Bilateral erector spinae and pectoralis muscle (ESM&PM) were measured at defined vertebral levels. Results: FVC and DLCO decreased but within acceptable limits of treatment response (FVC: 83.7–78.7%, p < 0.05, DLCO 63.4–60.6%, p < 0.05). The cross-sectional area of the PM and ESM increased (PM: 39.8 to 40.7 cm2, p = 0.491; ESM: 35.2 to 39.5 cm2, p = 0.098). Density significantly fell for both the PM and ESM (PM: 35.3–31 HU, p < 0.05; ESM: 38–33.7, p < 0.05). Subcutaneous fat area increased from 103.9 to 136.1 cm2 (p < 0.05), while the visceral fat area increased but not reaching statistical significance. The change in PM density between time points demonstrated an inverse correlation with DLCO (p < 0.05, R = − 0.49). Conclusion: Patients with IIM ILD demonstrated significant body composition changes on CT imaging unlikely to be detected by traditional measurement tools. An increase in muscle area with an inverse decrease in density suggests poor muscle quality.

4 October 2017
Verified
Conference Paper
Closed access
PDF file
FSF Scottoni
F Scottoni
LULuca Urbani
Luca Urbani
CCC Camilli
C Camilli
DPD Phylactopoulos
D Phylactopoulos
EHE Hannon
E Hannon
PCPaolo De Coppi
Paolo De Coppi
Background Oesophageal atresia is a birth defect occurring in approximately 1 in 2500 live births. Tissue engineering is a promising therapeutic alternative for those patients requiring oesophageal replacement. Aim of this study is to evaluate the engraftment in vivo of the muscle compartment of an engineered rat oesophagus in a mouse model of heterotopic xeno-genic implant and to prove its capability to grow an epithelial layer ex vivo. Methods The detergent-enzymatic protocol was used to produce decellulirised rat oesophagi. Those were subsequently repopulated with smooth muscle (human mesoangioblasts) and neural (mouse neural crest stem cells) precursor. A 3D culture protocol in a bioreactor was used to maximise the cells engraftment, proliferation and differentiation in vitro. 4 engineered oesophagi were implanted in 4 immunodeficient mice and left in situ. After 2 weeks the animals were euthanised and the engineered organs harvested and seeded, on the luminal surface, with epithelial progenitors derived from rat oesophagi. Results Engraftment, proliferation and differentiation of both muscle and neural cells were achieved during the initial in vitro culture as evident from the immunofluorescence. Those features were also preserved after the implant in the mice omentum. The immunofluorescence showed the presence of new vessels inside the artificial oesophagi when harvested from the mice. The engineered oesophagi were able to grow an epithelial layer when progenitors were seeded ex vivo. Conclusion The effectiveness of the in vivo implant of the engineered oesophagi was demonstrated, underlying the survival of both muscle and neural cells thanks to angiogenetic phenomena. The generation, ex vivo, of an epithelial layer is really promising, making realistic a 2 stage surgical approach for clinical translation.